Rhythm Pharmaceuticals, Inc. (RYTM)
119.19
+2.58
(+2.21%)
USD |
NASDAQ |
Nov 18, 16:00
119.19
0.00 (0.00%)
After-Hours: 19:29
Rhythm Pharmaceuticals Total Return Level : 116.61 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 116.61 |
| November 16, 2026 | 107.48 |
| November 13, 2026 | 115.02 |
| November 12, 2026 | 109.86 |
| November 11, 2026 | 112.16 |
| November 10, 2026 | 113.95 |
| November 09, 2026 | 113.94 |
| November 06, 2026 | 112.28 |
| November 05, 2026 | 105.02 |
| November 04, 2026 | 110.68 |
| November 03, 2026 | 86.44 |
| November 02, 2026 | 93.44 |
| October 30, 2026 | 92.57 |
| October 29, 2026 | 93.07 |
| October 28, 2026 | 91.97 |
| October 27, 2026 | 92.18 |
| October 26, 2026 | 89.47 |
| October 23, 2026 | 89.27 |
| October 22, 2026 | 90.90 |
| October 21, 2026 | 88.62 |
| October 20, 2026 | 90.20 |
| October 19, 2026 | 88.23 |
| October 16, 2026 | 86.17 |
| October 15, 2026 | 87.97 |
| October 14, 2026 | 86.71 |
| Date | Value |
|---|---|
| October 13, 2026 | 86.61 |
| October 12, 2026 | 89.82 |
| October 09, 2026 | 90.78 |
| October 08, 2026 | 89.64 |
| October 07, 2026 | 88.45 |
| October 06, 2026 | 90.77 |
| October 05, 2026 | 92.45 |
| October 02, 2026 | 92.83 |
| October 01, 2026 | 93.41 |
| September 30, 2026 | 95.22 |
| September 29, 2026 | 95.71 |
| September 28, 2026 | 98.56 |
| September 25, 2026 | 98.66 |
| September 24, 2026 | 98.31 |
| September 23, 2026 | 98.24 |
| September 22, 2026 | 99.27 |
| September 21, 2026 | 98.83 |
| September 18, 2026 | 97.71 |
| September 17, 2026 | 99.02 |
| September 16, 2026 | 98.01 |
| September 15, 2026 | 96.77 |
| September 14, 2026 | 102.44 |
| September 11, 2026 | 104.71 |
| September 10, 2026 | 102.20 |
| September 09, 2026 | 101.06 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 156.50 |
| Arrowhead Pharmaceuticals, Inc. | 42.99 |
| BioMarin Pharmaceutical, Inc. | 58.51 |
| Cytokinetics, Inc. | 51.65 |
| Exelixis, Inc. | 68.50 |